Nonsteroidal anti-inflammatory drugs in chronic pain: implications of new data for clinical practice.
Kok Yuen Ho, Kok Ann Gwee, Yew Kuang Cheng...
https://pubmed.ncbi.nlm.nih.gov/30288088Actively Recruiting
Led by Iffat Anwar Medical Complex · Updated on 2024-09-04
100
Participants Needed
1
Research Sites
4 weeks
Total Duration
Researchers are evaluating different clinical techniques to treat patients with chronic low back pain (CLBP), a condition causing persistent pain for more than three months and affecting quality of life. The study compares conventional therapy using nonsteroidal anti-inflammatory drugs (NSAIDs) and physical therapy with a combination of neuromodulation and platelet-rich plasma (PRP) therapy. The goal is to see if neuromodulation via the dorsal root ganglion and PRP can provide better pain relief and improve function by reducing inflammation and modulating nerve pathways. Participants will be assigned randomly to one of two groups. The conventional therapy group will take NSAIDs daily as prescribed and attend physical therapy sessions twice a week. The neuromodulation plus PRP group will receive weekly neuromodulation sessions via dorsal root ganglion for the first month, followed by monthly maintenance if needed, and weekly PRP injections for the first three weeks. Both treatments involve monitoring and adjustments during the study. Throughout the study, participants will be regularly assessed for pain levels using the Visual Analog Scale (VAS), disability using the Oswestry Disability Index (ODI), and anxiety and depression with the Hospital Anxiety Depression scale (HAD) at multiple time points up to 12 months. Researchers will monitor adherence, side effects, and functional improvements during scheduled visits. The study will last over a year to evaluate both short-term and long-term outcomes for chronic low back pain management.
CONDITIONS
Assessment of Different Clinical Techniques to Treat Patients With Chronic Low Back Pain
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 12 months
Participants receive either conventional therapy, including daily NSAIDs and physical therapy sessions twice a week, or neuromodulation via the dorsal root ganglion combined with platelet-rich plasma (PRP) injections administered once a week for the first three weeks and maintenance neuromodulation sessions monthly if needed.
Physical therapy twice weekly; neuromodulation once weekly for first month, then monthly if needed; PRP injections once weekly for first three weeks
Duration - Up to 12 months
Participants are monitored for pain levels, functional improvement, and any side effects after completing treatment.
Visits at 2 weeks, 3 months, 6 months, and 12 months
Total: 1 location
1
Iffat Anwar Medical Complex
Lahore, Pakistan
Actively Recruiting
S
Shahzad Anwar, MBBS, DOM
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Kok Yuen Ho, Kok Ann Gwee, Yew Kuang Cheng...
https://pubmed.ncbi.nlm.nih.gov/30288088Timothy Deer, Jason Pope, Salim Hayek...
https://pubmed.ncbi.nlm.nih.gov/25395117Emily A Sundman, Brian J Cole, Vasili Karas...
https://pubmed.ncbi.nlm.nih.gov/24192391